Mesoblast Limited vs Rush Street Interactive Inc — how do they compare? Mesoblast Limited trades at $16.74 (market cap $2.20B), while Rush Street Interactive Inc trades at $24.45 (market cap $2.81B). The key difference: Rush Street Interactive Inc is the larger of the two by market cap. Which is the better fit depends on your goals.
| MESO | RSI | |
|---|---|---|
Market Cap | $2.20B | $2.81B |
Sector | Technology | Technology |
52-Week High | $20.96 | $34.52 |
52-Week Low | $12.88 | $15.89 |
Enterprise Value | $2.20B | $2.47B |
Signals from Pluang's Aura AI — not financial advice
MESO trades at $16.78, up 0.6% with a bullish technical signal from moving averages. The company shows strong revenue growth with Ryoncil generating $115M in its first year, but remains unprofitable with a -144% net margin. Recent milestones include Phase 3 trial completion for chronic back pain and BLA filing for heart failure treatment, indicating pipeline progress.
Investment outlook balances promising commercial traction against significant financial losses. The stock offers growth potential from expanding indications but carries high risk due to negative earnings and dependence on regulatory approvals. Analyst consensus leans bullish with 45% buy ratings, though profitability remains the key challenge.
Rush Street Interactive (RSI) trades at $24.28, down 1.78% over 24 hours, with a bearish technical signal from moving averages despite bullish oscillators. The company reported record Q2 2026 revenue of $393.8 million, up 46% year-over-year, and raised full-year guidance. Financials show strong revenue growth but thin net margins of 2.33%, with elevated valuation ratios like a P/E of 81.13. Analyst consensus is strongly bullish with a $34.75 price target.
The outlook is positive due to robust revenue growth and expansion in online casino and sports betting markets, but risks include high valuation sensitivity and competitive pressures. Institutional buying by firms like Dimensional Fund Advisors supports sentiment, though insider selling post-rally warrants monitoring. The stock offers growth potential if execution continues, but investors should weigh margin pressures against expansion prospects.
Trailing returns across standard periods
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →